ARTICLE | Company News
MedImmune Inc. infectious news
January 2, 2006 8:00 AM UTC
FDA approved MEDI's new influenza vaccine manufacturing facility in Speke, U.K. The company said the facility can produce up to 15 million bulk doses per month of its FluMist intranasal influenza vac...